Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Biological Psychiatry

• Publication date

  1988-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0006-3223(88)90188-6PMID 2841987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers

  2004cited by this paper
• Platelet [3H]imipramine binding in psychiatric disorders.

  1987cited by this paper
• Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.

  1986cited by this paper
• Demonstration of endogenous "imipramine like" material in rat brain.

  1985cited by this paper
• Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.

  1985cited by this paper
• Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls.

  1985cited by this paper
• Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.

  1984cited by this paper
• Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.

  1983cited by this paper
• 3H-imipramine binding sites in platelets from psychiatric patients.

  1982cited by this paper
• Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients.

  1980cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Is there a relationship between morphological and functional platelet changes and depressive disorder?

  2020cites this paper
• Effects of repetitive administration of tianeptine, zinc hydroaspartate and electroconvulsive shock on the reactivity of 5-HT(7) receptors in rat hippocampus.

  2007cites this paper
• Receptores 5HT2 y lugares de unión DE 3H-imipramina Y 3H-paroxetina en membrana de plaqueta en trastorno bipolar.

  2007cites this paper
• Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release

  2005cites this paper
• Theories on Mechanism of Action of Electroconvulsive Therapy

  2005cites this paper
• Electroconvulsive shock increases serotonin transporter in the rat frontal cortex.

  2003cites this paper
• Neurobiological Correlates of the Antidepressant Action of Electroconvulsive Therapy

  1998cites this paper
• Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depression.

  1997cites this paper
• Association between the serotonin transporter gene and affective disorder: The evidence so far

  1997cites this paper
• Electroconvulsive therapy down-regulates platelet peripheral-type benzodiazepine receptors in medication-resistant major depressed patients.

  1996cites this paper
• The serotonin transporter gene and affective disorder.

  1996cites this paper
• Is platelet imipramine binding reduced in depression? A meta-analysis.

  1994cites this paper
• Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.

  1994cites this paper
• A single electroconvulsive treatment affects platelet serotonin uptake in bipolar I patients.

  1993cites this paper
• Platelet imipramine binding in depressed children and adolescents.

  1992cites this paper
• Rapid changes in 3H‐imipramine platelet binding after chronic treatment with amineptine, a selective dopamine uptake blocker, in major depressed patients

  1992cites this paper
• Platelet 3H‐imipramine binding during recovery from depression

  1992cites this paper
• Circadian Variation in Platelet Imipramine Binding During the Day in Healthy Subjects

  1991cites this paper
• Circadian variation in platelet imipramine binding during the day in healthy subjects.

  1991cites this paper
• Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3 H‐imipramine binding and serotonin uptake and concentration in major depressive disorder

  1991cites this paper
• Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.

  1991cites this paper
• Platelet tritiated imipramine binding in patients suffering from mania.

  1991cites this paper
• Decreased seasonal mesor of platelet 3H-imipramine binding in depression.

  1991cites this paper
• Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients.

  1990cites this paper
• Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.

  1990cites this paper
• 3H-Imipramine Binding to Previously Frozen Platelet Membranes from Depressed Patients, Before and After Treatment

  1990cites this paper
• Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.

  1990cites this paper
• Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.

  1990cites this paper
• Neuropsychological and Biomedical Assessment of

  1989cites this paper